+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Conjugate Vaccine"

From
From
From
From
From
From
From
Pneumococcal Vaccines Market - Forecasts from 2022 to 2027 - Product Thumbnail Image

Pneumococcal Vaccines Market - Forecasts from 2022 to 2027

  • Report
  • May 2022
  • 110 Pages
  • Global
From
Global Paediatric Vaccine Market - Forecasts From 2018 to 2023 - Product Thumbnail Image

Global Paediatric Vaccine Market - Forecasts From 2018 to 2023

  • Report
  • November 2018
  • 105 Pages
  • Global
From
From
Menactra (Sanofi) Drug Overview 2019 - Product Thumbnail Image

Menactra (Sanofi) Drug Overview 2019

  • Report
  • September 2019
  • 12 Pages
  • Global
V114 - Product Thumbnail Image

V114

  • Report
  • December 2018
  • 15 Pages
  • Global
From
Synflorix - Product Thumbnail Image

Synflorix

  • Report
  • December 2018
  • 12 Pages
  • Global
From
Loading Indicator

The Conjugate Vaccine market is a subset of the Vaccines market, which is composed of products designed to prevent and treat infectious diseases. Conjugate Vaccines are a type of vaccine that combines a polysaccharide antigen with a protein carrier, which helps the body to recognize the antigen and mount an immune response. These vaccines are used to protect against a variety of bacterial infections, including meningitis, pneumonia, and sepsis. Conjugate Vaccines are typically administered to infants and young children, as their immune systems are not yet fully developed and are more susceptible to certain infections. In addition, these vaccines are often used in combination with other vaccines to provide broader protection against multiple diseases. Notable companies in the Conjugate Vaccine market include GlaxoSmithKline, Merck & Co., Pfizer, Sanofi, and Novartis. Show Less Read more